首页> 外国专利> Agent for treating primary liver cancer and a method of treating primary liver cancer

Agent for treating primary liver cancer and a method of treating primary liver cancer

机译:治疗原发性肝癌的药物和治疗原发性肝癌的方法

摘要

An agent is disclosed for suppressing the growth of tumour cells in primary liver cancer. It contains doxorubicin-estron as the active substance and lipiodol ultrafluid as the carrier, the latter containing a lyophilised preparation of human alpha foetoprotein. The proposed method of treating primary liver cancer involves the preparation of a solution of the active substance in lipiodol ultrafluid with the addition of alpha foetoprotein.
机译:公开了一种在原发性肝癌中抑制肿瘤细胞生长的药剂。它包含阿霉素雌激素作为活性物质和脂质碘超流质作为载体,后者包含人α甲胎蛋白的冻干制剂。所提出的治疗原发性肝癌的方法包括制备活性物质在碘油超流体中的溶液,并添加α-甲胎蛋白。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号